Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profiles.
Bhinder B, Friedl V, Sethuraman S, Risso D, Chiotti KE, Mashl RJ, Ellrott KP, Lee JA, Wong CK, Gyan K, Deshpande A, Imielinski M, Bareja R, Stuart J, Peto M, Hoadley KA, Lazar AJ, Cherniack AD, Zhu J, Cao S, Rubin M, Wang W, Bathe OF, Robine N, Ding L, Laird PW, Zhou W, Shen H, Thorsson V, Yeh JJ, Bailey MH, Zhou DC, Peng XL, Goldman M, Li Y, Korkut A, Sahni N, Hayes DN, Mensah MKA, Felau I, Kemal A, Caesar-Johnson S, Demchok JA, Yang L, Ferguson ML, Tarnuzzer R, Wang Z, Zenklusen JC; Cancer Genome Atlas Analysis Network; Spellman P, Elemento O.
Bhinder B, et al.
Sci Rep. 2025 Jul 4;15(1):23921. doi: 10.1038/s41598-025-09075-y.
Sci Rep. 2025.
PMID: 40615649
Free PMC article.